Showing results (81-90 of 346) with videos related to

Sort By:
Pageof 35
The Journal of Thoracic and Cardiovascular Surgery|August 24, 2012
Operative outcomes in mitral valve surgery: combined effect of surgeon and hospital volume in a population-based analysisArman Kilic, Ashish S Shah, John V Conte, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|December 15, 2019
Mortality and Readmissions After On-Pump Versus Off-Pump Redo Coronary Artery Bypass SurgeryEdgar Aranda-Michel, Valentino Bianco, Arman Kilic, et al.
Journal of Cardiac Surgery|August 9, 2021
Impact of center donor acceptance patterns on utilization of extended-criteria donors and outcomesNicholas R Hess, Laura M Seese, Ibrahim Sultan, et al.
Journal of Cardiac Surgery|May 25, 2019
Clinical outcomes and hospital readmission rates in mechanical vs bioprosthetic mitral valvesIbrahim Sultan, Valentino Bianco, Thomas G Gleason, et al.
Journal of Cardiac Surgery|January 23, 2021
Changes in multiorgan heart transplants following the 2018 allocation policy changeDerek K Afflu, Carlos E Diaz-Castrillon, Laura Seese, et al.
Circulation. Heart Failure|August 8, 2020
Intra-Aortic Balloon Pump Bridging to Heart Transplantation: Impact of the 2018 Allocation ChangeLauren V Huckaby, Laura M Seese, Michael A Mathier, et al.
General Thoracic and Cardiovascular Surgery|September 14, 2018
A running suture line for aortic valve replacement does not increase the rate of postoperative complete heart blockIbrahim Sultan, Keith A Dufendach, Arman Kilic, et al.
Surgical Endoscopy|December 29, 2012
Early outcomes of antireflux surgery for United States lung transplant recipientsArman Kilic, Ashish S Shah, Christian A Merlo, et al.
Journal of Cardiac Surgery|February 9, 2019
Longitudinal outcomes of dialysis-dependent patients undergoing isolated coronary artery bypass graftingValentino Bianco, Arman Kilic, Thomas G Gleason, et al.
The Journal of Surgical Research|December 17, 2008
Efficacy of signal pathway inhibitors alone and in combination with Cisplatin varies between human non-small cell lung cancer linesArman Kilic, Matthew J Schuchert, James D Luketich, et al.
Pageof 35